Search Within

Jaclyn Frances Hechtman

  1. "Michael Berger"
Formats
  1. Journal Article (33)
  2. Meeting Abstract (32)
  3. Research Letter (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (66)
  2. Department of Pathology and Laboratory Medicine (66)
  3. GSK Faculty (66)
  4. Human Oncology and Pathogenesis Program (66)
  5. Department of Medicine (60)
  6. Solid Tumor Oncology Division (60)

More Groups

People
  1. Michael Berger (66)
  2. David Solit (39)
  3. Jinru Shia (32)
  4. Nikolaus Schultz (30)
  5. Marc Ladanyi (26)
  6. Ahmet Zehir (25)

More People

Years
  1. 2025 (1)
  2. 2021 (4)
  3. 2020 (3)
  4. 2019 (15)
  5. 2018 (11)
  6. 2017 (10)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Clinical Cancer Research (8)
  3. Modern Pathology (5)
  4. Cancer Discovery (4)
  5. Cancer Research (4)
  6. Journal of Molecular Diagnostics (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (23)
  2. American Association for Cancer Research (17)
  3. Nature Publishing Group (7)
  4. Nature Research (5)
  5. Elsevier Science, Inc. (4)
  6. Oxford University Press (4)

More Publishers

Results (66)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A deep multiple instance learning framework improves microsatellite instability detection from tumor next generation sequencing
    Journal Article

    Ziegler, J.; Hechtman, J. F.; Rana, S.; Ptashkin, R. N.; Jayakumaran, G.; Middha, S.; Chavan, S. S.; Vanderbilt, C.; DeLair, D.; Casanova, J.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
    Journal Article

    Brannon, A. R.; Jayakumaran, G.; Diosdado, M.; Patel, J.; Razumova, A.; Hu, Y.; Meng, F.; Haque, M.; Sadowska, J.; Murphy, B. J.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Next-generation sequencing of 487 esophageal adenocarcinomas reveals independently prognostic genomic driver alterations and pathways
    Journal Article

    Sihag, S.; Nussenzweig, S. C.; Walch, H. S.; Hsu, M.; Tan, K. S.; Sanchez-Vega, F.; Chatila, W. K.; De La Torre, S. A.; Patel, A.; Janjigian, Y. Y.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Characterization and clinical outcomes of DNA mismatch repair-deficient small bowel adenocarcinoma
    Journal Article

    Latham, A.; Shia, J.; Patel, Z.; Reidy-Lagunes, D. L.; Segal, N. H.; Yaeger, R.; Ganesh, K.; Connell, L.; Kemeny, N. E.; Kelsen, D. P.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • TRK XDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Journal Article

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arruabarrena-Aristorena, A.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Meeting Abstract

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arena, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Prevalence and clinical characterization of MMR-D/MSI extra-colonic cancers among germline PMS2 mutation carriers
    Meeting Abstract

    Latham, A.; Salo-Mullen, E. E.; Catchings, A.; Ranganathan, M.; Fiala, E.; Kemel, Y.; Konner, J. A.; Soslow, R. A.; Momeni-Boroujeni, A.; Shia, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Regorafenib in combination with first-line chemotherapy for metastatic esophagogastric cancer
    Journal Article

    Moy, R. H.; Dos Santos Fernandes, G.; Jonsson, P.; Chou, J. F.; Basunia, A.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • Genomic characterization of ERBB2-driven biliary cancer and a case of response to ado-trastuzumab emtansine
    Journal Article

    Mondaca, S.; Razavi, P.; Xu, C.; Offin, M.; Myers, M.; Scaltriti, M.; Hechtman, J. F.; Bradley, M.; O'Reilly, E. M.; Berger, M. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Real-world outcomes of an automated physician support system for genome-driven oncology
    Journal Article

    Tao, J. J.; Eubank, M. H.; Schram, A. M.; Cangemi, N.; Pamer, E.; Rosen, E. Y.; Schultz, N.; Chakravarty, D.; Philip, J.; Hechtman, J. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save